Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaThe biology and treatment of EML4-ALK non-small cell lung cancerMolecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomasEmerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersGenomic sequencing in cancerMicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical useCIViC databaseIdentification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinibInhibitors of the anaplastic lymphoma kinaseALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsRenal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrumBreakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer typesSingle-cell SNP analyses and interpretations based on RNA-Seq data for colon cancer research.Absence of anaplastic lymphoma kinase translocations in signet ring cell carcinomas of the upper gastrointestinal tract.Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.ALK-rearrangements and testing methods in non-small cell lung cancer: a reviewIdentification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the HaystackNew aspects of neuroblastoma treatment: ASPHO 2011 symposium reviewTranscriptome instability as a molecular pan-cancer characteristic of carcinomasIdentification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell linesIdentification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression dataGene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.The mutation spectrum revealed by paired genome sequences from a lung cancer patient.Evaluating translocation gene fusions by SNP array data.Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue onlyLung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.ALK-driven tumors and targeted therapy: focus on crizotinibThe landscape of kinase fusions in cancerClinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancerNon-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.Transcriptional consequences of genomic structural aberrations in breast cancer.
P2860
Q21129306-E78D236D-8F4E-42F6-9BE0-1C16B635DE4CQ24632625-1D24B39F-00C6-494E-980E-E9025A4E361AQ26752945-974CF8BF-EE53-44E9-9B53-2223BA0B1536Q26766271-D444A433-A3BD-4428-96C8-C1C252C4D9B0Q26853507-3FC6F68B-7052-458A-A002-139BB7211C3AQ26861185-DD9B79BA-6137-45B2-A4A5-050958DE9798Q27612411-D7E322FA-A021-451B-A346-962162779756Q27851704-49555FAD-5685-47B4-B904-08E9666D3DFBQ27852699-96B561DE-1701-4B41-8BAA-CC77C7E9FF7EQ27853092-C9BE3084-1B0D-47DE-83D1-35CB5286DFEDQ27853136-04720BE4-B60C-438F-A002-72EBE5255B08Q28083711-6A3031DA-A140-4FD6-8641-207940177B4AQ28267124-8C3A8D7D-6EF8-495F-BF20-F93721A50D80Q28269764-62161501-2EE0-40F0-B1D6-67FB6D9E650AQ28298351-69534343-885A-404D-9FF9-81D7FD0098D1Q28486949-6FDB5F03-3DB7-4949-A2E7-CC53ADC38221Q31133433-3AF2A6AF-17D3-485A-A049-45BE7FB3744CQ33557250-750A45F4-B35D-4E33-A4AB-E6816C975135Q33758978-8D4783F3-4D15-48D4-8E86-D5EB342B644CQ33776835-9B437A2C-36C0-4C65-BF68-DD9FAEC53A2AQ33793930-A9798D92-B4B3-44B7-837F-32BA1C58AD1BQ33844713-0CBCCA95-DB6A-42F8-9DDB-4E98298CA0FAQ33898865-745E7F96-E81A-4DEF-8C8A-923CEA0DAAA5Q33898894-EB6D66CC-1206-478D-AE0D-D7C44197672EQ33922797-181113C0-335A-480A-A623-01FFE5451B72Q34041693-4D06DF6C-848D-4AF1-827F-CE58BFCD6FA2Q34060031-D3B9551D-EACF-486B-9AA8-0250FB4380FEQ34060354-042FFABC-0AF3-47FF-A7E0-E39E87507447Q34084819-0D9E369F-02CF-47B3-8069-C5184907223FQ34117627-6604C3B3-5A83-40CE-A059-14774BF6B508Q34132911-E931981D-111F-4862-B00A-2D5D75200474Q34136298-AA9BF6F1-AAF4-4954-A1A3-D2D99CBDB29AQ34162787-29FCCAA7-138A-4F0E-9C50-CBD8C4B39117Q34281228-C6329B71-D769-4F38-A5D8-C97D892A0CDEQ34353920-186D13C1-9357-4CE2-B362-4A3C19469809Q34414378-D4BF567A-5508-43C2-B969-48420862E321Q34437602-4BD8949C-EBFF-4607-9390-A455A302FCC8Q34558207-9F78B558-8783-4354-8D95-AAA986560B7DQ34558586-77902B86-288C-4985-96E1-3DA67BF5FF27Q34867822-E2125A90-0B8B-43BA-909C-E1A138AEC35C
P2860
Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Exon array profiling detects E ...... d non-small cell lung cancers.
@ast
Exon array profiling detects E ...... d non-small cell lung cancers.
@en
Exon array profiling detects E ...... d non-small cell lung cancers.
@nl
type
label
Exon array profiling detects E ...... d non-small cell lung cancers.
@ast
Exon array profiling detects E ...... d non-small cell lung cancers.
@en
Exon array profiling detects E ...... d non-small cell lung cancers.
@nl
prefLabel
Exon array profiling detects E ...... d non-small cell lung cancers.
@ast
Exon array profiling detects E ...... d non-small cell lung cancers.
@en
Exon array profiling detects E ...... d non-small cell lung cancers.
@nl
P2093
P3181
P1476
Exon array profiling detects E ...... d non-small cell lung cancers.
@en
P2093
Ajay Pandita
Jerry Tang
Robert Soriano
Sankar Mohan
Yinghui Guan
P304
P3181
P356
10.1158/1541-7786.MCR-08-0522
P407
P577
2009-09-01T00:00:00Z